About

Publications While At HealthPartners

selected publications

Journal Article

DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatide. 

Diabetic Medicine. 2011

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial. 

Lancet (London, England). 2010

Contact

full name

J. Malloy

Quick Info

 

Collaboration

Co-author network

Map of science